Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abecma, AboundBio, Acad, accordane, acquiree, Addendum, affinity, aggressive, aggressively, albeit, alien, allergy, allogeneic, Alserawan, amortised, anaemia, Andorra, aniticpated, antigen, arguably, argument, ASH, ASP, Astra, ATALANTA, Aug, automated, axial, axspa, bacteria, bankruptcy, BCMA, Betriu, bimekizumab, Bimzelix, binder, binutuzumab, Biocad, bispecific, Blackstone, bottom, Brauw, Breyanzi, broadest, BTKi, bullet, buyer, CAGR, CallPoint, Carvykti, Castle, CAT, catch, Cattolica, cellpoint, cenerimod, cerebral, characterised, chemotherapy, Chimeric, clarified, clinicopathological, CLL, Cnossen, coaching, Cocoon, Comittee, Commitee, Commmittee, commuting, compliant, constantly, contraindication, Convergence, cooptation, Cosmetic, counter, County, CPK, Cravath, CRR, cryopreservation, cultivated, DCF, DEA, deeper, defence, dendritic, Dermatol, deter, dismal, diversification, DM, drastically, Ds, echange, edema, editing, effector, EHA, Eli, England, entrepreneurship, entrusted, escape, ESG, Esteban, euplagia, Fab, fashion, faster, FDIC, FDORA, febrile, fertility, FIAM, Fidelity, fifteen, focussed, Fontainebleau, fourteenth, fresh, Friday, frozen, functionnning, Galloway, god, Goreshi, grown, hallmark, harvesting, hematologic, hematological, Hematology, HM, HMT, hormone, hour, HR, HRQoL, HSBC, hypercalcemia, Hypertrust, ICAN, Idorsia, IEC, IIM, immunoglobulin, immunoregulatory, immunotherapy, incidentally, indepence, indolent, infusion, Interchangeability, interchangeable, Intervest, intubation, Israel, Italian, Janurary, Jemal, KD, Kymriah, language, Leaseback, LEO, lesser, leukemia, logistical, Lonza, loosened, Louisiana, lymp, lymph, lymphatic, lymphodepletion, lymphoid, lymphoma, lymphoproliferative, lytic, Mackensen, manipulation, Mantle, Marino, marrow, mentor, merit, microbial, migrate, Milano, Miller, Missotten, MO, Molecure, Monaco, Montoro, Moore, Mougiakako, Muyden, myeloma, myopathy, Nat, navigate, necessitate, necessitated, neoplastic, Netakimab, neuropsychiatric, neurotoxicity, neutral, neutropenia, NHL, notable, notably, nrAxSpA, Octagam, Octapharma, Oegstgeest, onboarded, opposed, Orange, ORR, osteolytic, osteopenia, ot, Paresh, pathologic, payor, PHEIC, Philadelphia, Philology, phosphorylated, PHS, physiotherapy, Pittsburgh, plasma, Ploughshare, Pont, poster, PR, PRA, predicated, preset, prespecified, priorconsent, proceeding, ProDerm, proliferate, proliferation, Prudential, psychology, purified, quicky, radiographic, RC, rebuild, receivership, reclassification, recognizable, refractory, refrain, reinforce, reinforced, rental, replapsed, Rescue, reshaping, revolving, Richter, rl, RMP, RoActemra, Roman, routine, rrCLL, rrMM, rrNHL, rrSLL, rSLE, RT, Saab, scalable, scFv, SELECTIONLTE, Sep, sex, Silicon, Silvergate, skeletal, SLL, smoke, SmPC, Sorbonne, Sotyktu, speech, spleen, Spoon, steeply, stored, stroke, suboptimal, sudden, superfamily, supplier, SVB, SVBUK, Swaine, swept, symptomatic, Talent, technique, teleworkable, testicular, thrombocytopenia, tighter, TIL, traditional, transducer, troubled, umbrella, uncontrolled, underscore, undrawn, unethical, uninsured, unmanaged, unveiled, unwinding, uptake, urine, vacant, Valeria, Valley, variance, vasopressor, Vatican, ventilation, Vershueren, VH, wage, warehouse, Watch, Westbroek, Whilst, whistleblower, widespread, Wilmington, workflow, wthout, xcellit, yeast, Yescarta, Zeneca
Removed:
Abbott, achievable, activate, activated, adjacent, administering, AG, air, alpha, AMP, Amphista, Anomeric, antagonist, antidilutive, apportioned, Assistant, AtD, atopic, autotaxin, azathioprine, Beirut, Benelux, biochemical, Biogen, Bipartisan, blockage, Boehringer, breath, campaign, capitalisation, Carlo, cathepsin, Celgene, certolizumab, chairperson, CNS, Commerce, Condensed, constitutional, Cornell, correlation, Cromwell, CSR, cure, DCPrime, declaring, deficiency, derecognition, derecognized, diarrhea, dioxide, discussing, dispensed, DNA, dormant, DPI, dropped, DSM, Dysregulation, Ear, enactment, Enbrel, Endocrinology, Epilepsy, Esbriet, Estonia, etanercept, examination, exit, explanatory, explore, expression, eye, fecal, fibroblast, Fibrogen, fibrotic, fight, formula, Genocea, genome, Goldman, golimumab, graduated, ground, Harvard, Hayfin, HDL, headed, Hemoglobin, highlight, histopathology, hypothetical, Idec, India, infect, Ingelheim, ingesting, inhibiting, injectable, interfering, intervene, IntroGene, Invitrogen, ixekizumab, JD, Joseph, KGaA, killing, knee, knock, largest, Latin, lawyer, Lebanon, Leiden, lorecivivint, lowest, matching, maximize, MedAvante, Medivir, Microscopic, minimal, MOGEN, Monte, monthly, mRNA, MSc, mutually, nail, nanobody, nausea, Neuroscience, Neurosurgery, Neutrophil, nintedanib, nondeductible, nurse, Ofev, offsetting, optimization, optimized, output, pamrevlumab, Paradise, partnered, periodically, pharmaceutically, phenotype, piece, pioneering, pirfenidone, pollution, positively, postdoctoral, Poverty, prednisolone, preparatory, productivity, prolong, Pso, Psychiatry, Psychobiology, readout, recombinant, relentlessly, repealed, replicate, replication, retail, RNA, ROCCELLA, rolled, root, SA, Saint, Samumed, SAS, scarring, Schizophrenia, secukinumab, sequence, Shire, shRNA, shuttle, simulation, siRNA, situ, Slovakia, Slovenia, SmallBone, Southern, sprifermin, standing, subsidy, substitution, Sullivan, sulphasalazine, suppression, survey, Syngenta, Tabular, Taiwan, today, Toledo, tractable, traditionally, universe, Universit, vehicle, VitalNext, Wageningen, wnt, worse, worsening, Yale
Filing tables
Filing exhibits
GLPG similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference into the Company’s Registration Statement on Form S-8 Nos. 333-268756, 333-260500, 333-249416, 333-231765, 333-225263, 333-218160, 333-215783, 333-211834, 333-208697, 333-204567 of our reports dated March 23, 2023, relating to the financial statements of Galapagos NV and the effectiveness of Galapagos NV's internal control over financial reporting appearing in this Annual Report on Form 20-F for the year ended December 31, 2022.
| |
Zaventem, Belgium, March 23, 2023 | |
| |
/s/ Deloitte Bedrijfsrevisoren / Réviseurs d’Entreprises BV/SRL | |
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises BV/SRL | |
| |
| |